HealthCare Global Enterprises Ltd (HCG) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by HealthCare Global Enterprises Ltd on NSE and BSE, with an AI summary of each filing.
Further to our intimation made on October 13, 2026, regarding the meeting of the Board of Directors of the Company scheduled to be held on Thursday, November 05, 2026, inter alia, to consider, ....
Intimation · 06 Nov 2026, 12:30 pm
HealthCare Global Schedules Q2 & H1 FY27 Earnings Call on 6th Nov'26 HealthCare Global Enterprises Limited (HCG) has scheduled its Q2 & H1 FY27 earnings conference call for 6th Nov'26 at 12:30 PM IST. The call follows the Board of Directors' meeting on 5th Nov'26 to approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Senior management will host a brief discussion followed by a Q&A session. Primary dial-in numbers are +91 22 6280 1141 and +91 22 7115 8042, alongside international toll-free access.
HEALTHCARE GLOBAL ENTERPRISES LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 05 Nov 2026, 5:30 am
To consider and approve the unaudited financial results of the Company for the quarter and six months ended September 30, 2026.
Intimation · 05 Nov 2026, 5:30 am
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve inter-alia the ....
Intimation · 05 Nov 2026, 5:30 am
HealthCare Global Enterprises Board to Consider Q2 FY27 Results on 5th Nov'26 HealthCare Global Enterprises announced that its Board of Directors is scheduled to meet on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company shares has been closed for all designated persons and their immediate relatives starting 1st Oct'26, and will remain closed until 48 hours post the declaration of the financial results.
Pursuant to Regulation 30 of SEBI Listing Regulations, we would like to inform you that Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e., ....
Others (Uncategorized) · 06 Oct 2026, 12:47 am
HCG Acquires Majority Stake in Kenya’s Advanced Molecular Imaging Healthcare Global Enterprises Limited’s step-down subsidiary, Healthcare Global (Kenya) Private Limited, acquired an additional 10 ordinary shares (0.10% stake) in Kenya-based Advanced Molecular Imaging Limited (AMIL) from Meditec Systems Limited on 5th Oct'26. The cash transaction was completed for KES 42,150 (~INR 31,288). Consequently, HCG Kenya increased its stake from 50% to 50.10%, transitioning AMIL from an associate into a step-down subsidiary of HCG. AMIL operates in molecular/diagnostic imaging and generated revenue of INR 10.96 Cr for the year ended 31st Dec'25.
Scrutinizer''s Report and Voting Results for the agenda(s) listed in the Notice of 28th Annual General Meeting of the Company.
Annual General Meeting · 19 Sept 2026, 3:46 am
Intimation regarding summary of proceedings of 28th Annual General Meeting of the Company.
Annual General Meeting · 19 Sept 2026, 2:12 am
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure requirements), Regulations 2015
Intimation · 17 Sept 2026, 8:28 pm
HealthCare Global Schedules Analyst and Institutional Investor Meeting in Mumbai HealthCare Global Enterprises Limited (NSE: HCG, BSE: 539787) informed exchanges under SEBI LODR Regulation 30(6) that company officials will participate in an investor/analyst interaction on 22nd Sep'26 in Mumbai at 8:00 AM. Hosted by Prabhudas Lilladher Private Limited, the event entails both one-on-one and group meetings. Management stated that all discussions will rely strictly on publicly available information.
Intimation of Schedule of meetings with Institutional Investors at Mumbai.
Intimation · 16 Sept 2026, 11:09 pm
HealthCare Global Enterprises to Attend Anand Rathi Annual Flagship Conference HealthCare Global Enterprises Limited announced that company officials will participate in analyst and institutional investor meetings on 21st Sep'26 starting at 9:00 AM in Mumbai. Hosted by the Anand Rathi Annual Flagship Conference G-200 Summit 2026, the interactions will include one-on-one and group meetings. All discussions will adhere strictly to publicly available information without sharing unpublished price-sensitive data.
The Nomination and Remuneration Committee of the Board of Directors of the Company, at its meeting held today, i.e., September 09, 2026, has approved grant of Employee Stock Options to ....
Others (Uncategorized) · 10 Sept 2026, 12:25 am
HealthCare Global Approves Grant of 6.45 Million Stock Options Under ESOS 2026 HealthCare Global Enterprises approved the grant of 64,46,843 employee stock options on 9th Sep'26 under the HCG ESOS 2026 scheme to eligible employees of the company, its subsidiaries, and associates. Each option converts into one equity share (face value INR 10) at an exercise price of INR 495 per share. The options carry a vesting period ranging between 1 to 7 years from the grant date, with an exercise window of up to 10 years commencing after 6 years or upon a change in control event.
Please note that letters are being dispatched to the Members of the Company containing web link and path of Integrated Annual Report for Financial Year 2025-26.
Annual Report · 28 Aug 2026, 7:22 pm
Please find enclosed the Notice of 28th Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26.
Annual General Meeting · 28 Aug 2026, 3:24 am
Please find enclosed the Integrated Annual Report of the Company for FY 2025-26.
Others (Uncategorized) · 28 Aug 2026, 3:12 am
Please find enclosed the Business Responsibility and Sustainability Report ("BRSR") of the Company for FY 2026.
Others (Uncategorized) · 27 Aug 2026, 6:55 pm
HCG Submits FY26 Business Responsibility and Sustainability Report HealthCare Global Enterprises (NSE: HCG) submitted its Business Responsibility and Sustainability Report for FY26 on 27 Aug'26. For FY26, the company reported total energy consumption of 170,621 GJ, a decrease from 194,224 GJ YoY. Total Scope 1 and 2 GHG emissions were 30,484 tCO2e, down from 34,885 tCO2e. Employee turnover for permanent staff improved to 25% from 31% in FY25. The company reported zero complaints for data privacy or advertising and no product recalls, but noted a potential marketing data breach incident is under investigation.
Please find attached herewith the Transcript of Earnings Call held on August 07, 2026, with Analysts/Investors to discuss the Unaudited Financial Results (Standalone and Consolidated) of ....
Transcript · 10 Aug 2026, 11:44 pm
This is to inform that the Company will be participating in the group investor meeting hosted by Ambit Capital in Bangalore.
Intimation · 08 Aug 2026, 12:32 am
HCG to Meet Investors at Ambit Capital's Healthcare Day HealthCare Global Enterprises (HCG) has announced its participation in an investor and analyst meeting. The meeting, hosted by Ambit Capital as part of its "Bangalore Healthcare Day," will take place in Bangalore on 12th Aug'26, starting from 03:00 p.m. Discussions will be based on publicly available information.
This is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on August 07, 2026, to discuss the Unaudited Financial Results (Standalone and Consolidated) ....
Audio / Video · 07 Aug 2026, 11:50 pm
HCG Q1FY27 Earnings Call Recording Made Available HealthCare Global Enterprises (HCG) has made the audio recording of its earnings call available on its investor relations website. The call, held on 07 Aug'26 with analysts and investors, discussed the company's unaudited standalone and consolidated financial results for the first quarter ended 30 Jun'26. This follows the company's regulatory intimation under SEBI's Listing Obligations and Disclosure Requirements.
Press release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Press Release · 07 Aug 2026, 2:15 am
HCG Q1FY27 Results: Strong Revenue Growth and Margin Expansion HealthCare Global Enterprises reported strong Q1FY27 results, with consolidated revenue rising 13% YoY to ₹6,951 Mn, driven by 11% volume growth. Adjusted EBITDA grew 20% YoY to ₹1,339 Mn, with margins expanding 121 bps to 19.4%. Adjusted PAT surged 190% YoY to ₹138 Mn. Growth was broad-based, with 16 of 25 centers posting record revenues. The company commissioned a new 120+ bed hospital in North Bangalore and added 121 operational beds across its network during the quarter ended 30 Jun'26.
Investor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Investor Presentation · 07 Aug 2026, 2:10 am
HCG Q1FY27: Strong YoY Growth Driven by Volume and Margin Expansion HealthCare Global Enterprises reported strong Q1FY27 results, with revenue growing 13% YoY to INR 6,951 Mn, led by an 11% YoY increase in volumes. Adjusted EBITDA grew 20% YoY to INR 1,339 Mn, and margins expanded by 121 bps to 19.4% from 18.2% in Q1FY26, driven by improved revenue quality. Profit after tax surged 190% YoY to INR 138 Mn. The company added 121 operational beds QoQ, reaching 2,855, and operationalized its North Bengaluru hospital in May'26.
Monitoring Agency Report for the quarter ended June 30, 2026, in relation to the Rights Issue of the Company..
Others (Uncategorized) · 07 Aug 2026, 2:02 am
HCG Rights Issue Proceeds Fully Utilized in Q1FY27 with No Deviation CARE Ratings' monitoring report for the quarter ended 30 Jun'26 confirms Healthcare Global Enterprises fully utilized its ₹424.68 crore Rights Issue proceeds with no deviation from stated objectives. During Q1FY27, ₹170 crore was used for debt prepayment, ₹154.04 crore for acquiring a 34% stake in Vizag Hospital, and ₹95.83 crore for general corporate purposes. Issue-related expenses were ₹4.81 crore against a planned ₹5.07 crore, with the ₹0.26 crore surplus reallocated to corporate purposes, all in line with the offer document.
Statement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30, 2026.
Others (Uncategorized) · 07 Aug 2026, 1:57 am
HCG Confirms No Deviation in Rights Issue Fund Utilisation for Q2'26 HealthCare Global Enterprises confirms no deviation in the utilisation of its Rs. 424.68 crore Rights Issue proceeds for the quarter ended 30 Jun'26. The funds, raised on 27 Mar'26, were used as per the offer document. Key allocations include Rs. 170.00 crore for debt repayment, Rs. 154.04 crore for stake acquisition, and Rs. 95.83 crore for general corporate purposes. A minor reallocation of Rs. 0.26 crore from issue expenses to corporate purposes was noted, which is within prescribed SEBI limits.
The Board of Directors has approved the re-appointment of M/s Rao Murthy & Associates, Cost Accountants as Cost Auditors of the Company for the financial year 2026-27.
Change in Management · 07 Aug 2026, 1:46 am
HCG Re-appoints M/s. Rao Murthy & Associates as Cost Auditor for FY27 HealthCare Global Enterprises' Board of Directors, at its meeting on 06 Aug'26, approved the re-appointment of M/s. Rao Murthy & Associates (Firm Registration No. 000065) as the company's Cost Auditor. The appointment is for the financial year 2026-27. This decision aligns with the company's regulatory compliance under SEBI's LODR Regulations.
The Board of Directors of the Company has approved a further investment of up to INR 16 Crores in HCG Rajkot Hospitals LLP, a wholly-owned subsidiary of the Company.
Others (Uncategorized) · 07 Aug 2026, 1:13 am
HCG to Invest INR 16 Crore in Wholly-Owned Rajkot Subsidiary HealthCare Global Enterprises' Board approved a further cash investment of up to INR 16 Crore in its wholly-owned subsidiary, HCG Rajkot Hospitals LLP, on 06 Aug'26. The funds are designated for debt repayment, working capital, and general corporate purposes. HCG will maintain its 100% shareholding post-investment. The Rajkot hospital, a 147-bed cancer specialty center, reported a turnover of INR 60.67 Crore for the financial year ending 31 Mar'26. The investment is expected to be completed by 30 Sep'26.
Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
Financial Result · 07 Aug 2026, 12:44 am
HCG Q1FY27: Revenue Rises 13% YoY, PAT Jumps to Rs 16.46 Crore HealthCare Global Enterprises reported consolidated Q1FY27 results, with revenue from operations up 13.3% YoY to Rs 693.39 crore. Profit After Tax (PAT) stood at Rs 16.46 crore, compared to Rs 5.98 crore in Q1FY26, a significant increase. Basic EPS was Rs 0.92 versus Rs 0.34 in the prior year's quarter. The Board also approved a further investment of up to Rs 16 crore in its wholly-owned subsidiary, HCG Rajkot Hospitals LLP, for the financial year 2026-27.
The Company has announced the Outcome of the Board meeting held on August 06, 2026, including approval of unaudited financial results of the Company for the quarter ended June 30, 2026.
Outcome · 07 Aug 2026, 12:28 am
HealthCare Global Enterprises Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 69,339 (+13.3% YoY | +6.6% QoQ) ■ EBITDA: 12,226 (+13.4% YoY | -2.3% QoQ) ■ EBITDA Margin (%): 17.6 (+1 bps YoY | -160 bps QoQ) ■ PAT: 1,377 (+189.9% YoY | +534.6% QoQ) ■ EPS (INR): 0.92 (+178.8% YoY | +513.3% QoQ)